Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPension (IS)Profit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GE HealthCare Technologies (GEHC) Shares Outstanding (Weighted Average) (2022 - 2025)

GE HealthCare Technologies (GEHC) has disclosed Shares Outstanding (Weighted Average) for 4 consecutive years, with $456.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding (Weighted Average) changed 0.0% year-over-year to $456.0 million, compared with a TTM value of $456.0 million through Dec 2025, changed 0.0%, and an annual FY2025 reading of $456.0 million, changed 0.0% over the prior year.
  • Shares Outstanding (Weighted Average) was $456.0 million for Q4 2025 at GE HealthCare Technologies, roughly flat from $456.0 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $457.0 million in Q1 2025 and bottomed at $454.0 million in Q1 2022.
  • Average Shares Outstanding (Weighted Average) over 4 years is $455.3 million, with a median of $455.5 million recorded in 2023.
  • The sharpest move saw Shares Outstanding (Weighted Average) changed 0.0% in 2023, then increased 0.44% in 2024.
  • Year by year, Shares Outstanding (Weighted Average) stood at $454.0 million in 2022, then grew by 0.22% to $455.0 million in 2023, then rose by 0.22% to $456.0 million in 2024, then changed by 0.0% to $456.0 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for GEHC at $456.0 million in Q4 2025, $456.0 million in Q3 2025, and $457.0 million in Q2 2025.